Andrei Laikhter

This inventor holds 15 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Integrated Dna Technologies, Inc., Chemgenes Corporation. Active years: 2008-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrei Laikhter. Retrieved from https://idiyas.com/inventor/andrei-laikhter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 73.3

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 147(Granted Patents)

Location History:

Iowa City, IA (US) (2008 - 2012)
Lexington, MA (US) (2011 - 2017)

Company Filing History:

12 out of 111

Integrated Dna Technologies, Inc.

patents

3 out of 21

Chemgenes Corporation

patents

Years Active: 2008-2017

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9540515 - Fluorescence quenching azo dyes, their methods of preparation and use (2017-01-10),

2. 8618279 - Synthesis of 2',3′— and 3′,5′—cyclic phosphate mono-and oligonucleotides (2013-12-31),

3. 8530634 - Method of oligonucleotide labeling using cycloaddition reaction (2013-09-10),

4. 8377641 - Fluorescence quenching azo dyes, their methods of preparation and use (2013-02-19),

5. 8258276 - Compounds and methods for labeling oligonucleotides (2012-09-04),

6. 8114979 - Di-alpha amino anthraquinone compositions (2012-02-14),

7. 8084588 - Fluorescence quenching azo dyes, their methods of preparation and use (2011-12-27),

8. 8030460 - Compounds and methods for labeling oligonucleotides (2011-10-04),

9. 7956169 - Synthesis of novel azo-dyes and their use in oligonucleotide synthesis (2011-06-07),

10. 7803936 - Compounds and methods for labeling oligonucleotides (2010-09-28),

11. 7803536 - Methods of detecting fluorescence with anthraquinone quencher dyes (2010-09-28),

12. 7645872 - Compounds and methods for labeling oligonucleotides (2010-01-12),

13. 7605243 - Compounds and methods for labeling oligonucleotides (2009-10-20),

14. 7476735 - Compounds and methods for labeling oligonucleotides (2009-01-13),

15. 7439341 - Fluorescence quenching azo dyes, their methods of preparation and use (2008-10-21),

Title: Andrei Laikhter: Innovator in Nucleic Acid Chemistry

Introduction

Andrei Laikhter is a prominent inventor based in Iowa City, IA (US), known for his significant contributions to the field of nucleic acid chemistry. With a total of 15 patents to his name, Laikhter has made remarkable advancements that have implications in therapeutics and diagnostics.

Latest Patents

One of Laikhter's latest patents is focused on fluorescence quenching azo dyes. This invention discloses a group of azo quencher compositions that are useful as fluorescence quenchers, along with methods for their preparation and use. Another notable patent involves the synthesis of 2',3'-cyclic phosphate mono- and oligonucleotides. This invention provides a novel method for the chemical synthesis of these nucleotides, which are crucial for various applications in molecular biology, particularly in mammalian cells.

Career Highlights

Throughout his career, Laikhter has worked with reputable companies such as Integrated DNA Technologies, Inc. and Chemgenes Corporation. His work has significantly impacted the development of high-purity DNA and RNA, which are essential for drug design and selective inhibition of RNA sequences.

Collaborations

Laikhter has collaborated with notable professionals in his field, including Mark Aaron Behlke and Yawfui Yong. These collaborations have further enhanced his research and innovations in nucleic acid chemistry.

Conclusion

Andrei Laikhter's contributions to the field of nucleic acid chemistry through his patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in therapeutics and diagnostics, showcasing the importance of innovation in scientific research.

Profile summary based on public USPTO records.